- Epigenetic regulation of hepatic Dpp4 expression in response to dietary protein
Sophie Saussenthaler et al, 2019, The Journal of Nutritional Biochemistry CrossRef - Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block
Vasilios G. Athyros et al, 2020, Current Vascular Pharmacology CrossRef - Liver and insulin resistance: New wine in old bottle!!!
Bhoomika M. Patel et al, 2019, European Journal of Pharmacology CrossRef - Metformin induces pyroptosis in leptin receptor-defective hepatocytes via overactivation of the AMPK axis
Bingli Liu et al, 2023, Cell Death & Disease CrossRef - Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis–associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects
Mitsuhiro Kawakubo et al, 2020, Scientific Reports CrossRef - Protective Effects of Evogliptin on Steatohepatitis in High-Fat-Fed Mice
Jin Hyun Kim et al, 2020, International Journal of Molecular Sciences CrossRef - Feprazone Displays Antiadipogenesis and Antiobesity Capacities in in Vitro 3 T3-L1 Cells and in Vivo Mice
Liqun Che et al, 2021, ACS Omega CrossRef - The Safety and Efficacy of Combining Saxagliptin and Pioglitazone Therapy in Streptozocin-Induced Diabetic Rats
Ahmed Mohamed Othman et al, 2023, Biomedicines CrossRef - Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
Minyoung Lee et al, 2020, Scientific Reports CrossRef - Effects of a DPP4 Inhibitor on Progression of NASH-related HCC and the p62/ Keap1/Nrf2-Pentose Phosphate Pathway in a Mouse Model
Takumi Kawaguchi et al, 2019, Liver Cancer CrossRef - DPP-4 inhibition resembles exercise in preventing type 2 diabetes development by inhibiting hepatic protein kinase Cε expression in a mouse model of hyperinsulinemia
Yu-peng Li et al, 2020, Journal of International Medical Research CrossRef - Discovery of dipeptidyl peptidase-4 inhibitor specific biomarker in non-alcoholic fatty liver disease mouse models using modified basket trial
Ju Hee Oh et al, 2022, Clinical and Molecular Hepatology CrossRef - Role of X-Box Binding Protein-1 in Fructose-Induced De Novo Lipogenesis in HepG2 Cells
Xian Yu et al, 2018, Chinese Medical Journal CrossRef - Bovine α-lactalbumin hydrolysates (α-LAH) attenuate high-fat diet induced nonalcoholic fatty liver disease by modulating hepatic lipid metabolism in C57BL/6J mice
Jing Gao et al, 2019, Journal of Functional Foods CrossRef - Dipeptidyl Peptidase-IV Inhibitory Activity and Related Molecular Mechanism of Bovine α-Lactalbumin-Derived Peptides
Jing Gao et al, 2020, Molecules CrossRef - A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease
Seonghwan Hwang et al, 2022, Clinical and Molecular Hepatology CrossRef - Ethanol Extract of Pinus koraiensis Leaves Mitigates High Fructose-Induced Hepatic Triglyceride Accumulation and Hypertriglyceridemia
Min-Ho Lee et al, 2022, Applied Sciences CrossRef - Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4
Mingfeng Yang et al, 2024, Clinical Nutrition CrossRef - From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
Amalia Gastaldelli et al, 2019, JHEP Reports CrossRef